0000905148-23-001027.txt : 20230928
0000905148-23-001027.hdr.sgml : 20230928
20230928163206
ACCESSION NUMBER: 0000905148-23-001027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230926
FILED AS OF DATE: 20230928
DATE AS OF CHANGE: 20230928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CPMG Inc
CENTRAL INDEX KEY: 0001372218
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 231290196
BUSINESS ADDRESS:
STREET 1: 4215 WEST LOVERS LANE
STREET 2: SUITE 100
CITY: DALLAS
STATE: TX
ZIP: 75209
BUSINESS PHONE: 214-871-6816
MAIL ADDRESS:
STREET 1: 4215 WEST LOVERS LANE
STREET 2: SUITE 100
CITY: DALLAS
STATE: TX
ZIP: 75209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Desai Antal Rohit
CENTRAL INDEX KEY: 0001881616
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 231290197
MAIL ADDRESS:
STREET 1: C/O PROCEPT BIOROBOTICS CORPORATION
STREET 2: 900 ISLAND DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001358762
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113651945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5320 LEGACY DRIVE
CITY: PLANO
STATE: TX
ZIP: 75024
BUSINESS PHONE: 972-865-2219
MAIL ADDRESS:
STREET 1: 5320 LEGACY DRIVE
CITY: PLANO
STATE: TX
ZIP: 75024
4
1
form4.xml
X0508
4
2023-09-26
true
0001358762
REATA PHARMACEUTICALS INC
RETA
0001881616
Desai Antal Rohit
4215 WEST LOVERS LN., STE 100
DALLAS
TX
75209
true
true
0001372218
CPMG Inc
4215 WEST LOVERS LN., STE 100
DALLAS
TX
75209
true
true
false
Class A common stock
2023-09-26
4
D
0
31467
D
0
I
By The 2:22 DNA Trust
Class A common stock
2023-09-26
4
D
0
113
D
0
I
By CPMG, Inc.
Class A common stock
2023-09-26
4
D
0
116512
D
0
I
By Nighthawk Partners, LP
Class A common stock
2023-09-26
4
D
0
282246
D
0
I
By Willet Fund, LP
Class A common stock
2023-09-26
4
D
0
137962
D
0
I
By Killdeer Fund, LP
Class A common stock
2023-09-26
4
D
0
5464
D
0
I
By Elepaio Partners, LP
Class A common stock
2023-09-26
4
D
0
44200
D
0
I
By Barred Owl Partners, LP
Class A common stock
2023-09-26
4
D
0
34897
D
0
I
By Managed Account for Trustees of the University of Pennsylvania
Class A common stock
2023-09-26
4
D
0
442560
D
0
I
By Gallopavo, LP
Class A common stock
2023-09-26
4
D
0
748253
D
0
I
By Roadrunner Fund, LP
Class A common stock
2023-09-26
4
D
0
431155
D
0
I
By Yellow Warbler, LP
Class A common stock
2023-09-26
4
D
0
109415
D
0
I
By Mallard Fund, LP
Class A common stock
2023-09-26
4
D
0
37909
D
0
I
By Crested Crane, LP
Class A common stock
2023-09-26
4
D
0
334740
D
0
I
By Sandpiper Fund, LP
Class A common stock
2023-09-26
4
D
0
160265
D
0
I
By Kestrel Fund, LP(
Class A common stock
2023-09-26
4
D
0
11076
D
0
I
By CD Fund, LP
Class A common stock
2023-09-26
4
D
0
134
D
0
I
By Redbird Life Sciences Partners, LP
Class B common stock
2023-09-26
4
D
0
1251
D
Class A common stock
1251
0
I
By CPMG, Inc.
Class B common stock
2023-09-26
4
D
0
150186
D
Class A common stock
150186
0
I
By Mallard Fund, LP
Class B common stock
2023-09-26
4
D
0
307776
D
Class A common stock
307776
0
I
By Kestrel Fund, LP
Class B common stock
2023-09-26
4
D
0
123279
D
Class A common stock
123279
0
I
By CD Fund, LP
Class B common stock
2023-09-26
4
D
0
1490
D
Class A common stock
1490
0
I
By Redbird Life Sciences Partners, LP
Class B common stock
2023-09-26
4
D
0
114946
D
Class A common stock
114946
0
I
By Willet Fund, LP
Class B common stock
2023-09-26
4
D
0
993929
D
Class A common stock
993929
0
I
By Yellow Warbler, LP
Mr. Desai and his spouse serve as co-trustees of The 2:22 DNA Trust.
CPMG, Inc. is the investment manager of each of: Nighthawk Partners, LP; Barred Owl Partners, LP; Killdeer Fund, LP; Crested Crane, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; Elepaio Partners, LP; CD Fund, LP; Redbird Life Sciences Partners, LP.; a managed account for Trustees of the University of Pennsylvania (collectively, the "Funds"). In such capacity, CPMG, Inc. may be deemed to have voting and investment power over the securities held directly by each of the Funds. Kent McGaughy, Jr. and Antal Desai, each of whom is a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the securities held directly by CPMG, Inc. and the Funds. Mr. McGaughy, Jr. reports his beneficial ownership of these securities on a separate Form 4.
Each of CPMG, Inc. and Mr. Desai (collectively, the "Reporting Persons") disclaims beneficial ownership of the securities reported herein except to the extent of its and his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or for any other purpose.
Pursuant to the Agreement and Plan of Merger, dated July 28, 2023, by and among the Issuer, Biogen Inc. ("Biogen") and River Acquisition, Inc., the Issuer became a wholly-owned subsidiary of Biogen upon consummation of the merger (the "Effective Time"). At the Effective Time, each of the Issuer's outstanding shares of Class A common stock and Class B common stock was canceled and extinguished and automatically converted into the right to receive $172.50 in cash, without interest, less any withholding taxes.
The Class B common stock was convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock had no expiration date.
Mr. McGaughy, Jr. serves on the Issuer's Board of Directors (the "Board") as a representative of CPMG, Inc. By virtue of his representation on the Board, for purposes of Section 16 of the Exchange Act, the Reporting Persons may be deemed to be directors of the Issuer by deputization of Mr. McGaughy, Jr.
/s/ Antal Rohit Desai
2023-09-28
/s/ John Bateman, Chief Operating Officer of CPMG, Inc.
2023-09-28